These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3129519)

  • 1. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity.
    Rustin MH; Bull HA; Machin SJ; Isenberg DA; Snaith ML; Dowd PM
    J Invest Dermatol; 1988 May; 90(5):744-8. PubMed ID: 3129519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lupus anticoagulant stimulates the release of prostacyclin from human endothelial cells.
    Petraiuolo W; Bovill E; Hoak J
    Thromb Res; 1988 Jun; 50(6):847-55. PubMed ID: 3137689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant.
    Mayumi T; Nagasawa K; Inoguchi T; Yamauchi Y; Ishii Y; Tada Y; Umeda F; Niho Y
    Ann Rheum Dis; 1991 Aug; 50(8):543-7. PubMed ID: 1909517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients.
    Watson KV; Schorer AE
    Am J Med; 1991 Jan; 90(1):47-53. PubMed ID: 1898838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus.
    de Prost D; Ollivier V; Ternisien C; Chollet-Martin S
    Thromb Haemost; 1990 Oct; 64(2):216-21. PubMed ID: 2125372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
    Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
    Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial prostacyclin release in systemic lupus erythematosus.
    Coade SB; van Haaren E; Loizou S; Walport MJ; Denman AM; Pearson JD
    Thromb Haemost; 1989 Feb; 61(1):97-100. PubMed ID: 2665169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.
    Schorer AE; Wickham NW; Watson KV
    Br J Haematol; 1989 Mar; 71(3):399-407. PubMed ID: 2495019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine and the lupus anticoagulant. Case reports and review of the literature.
    Levine SR; Joseph R; D'Andrea G; Welch KM
    Cephalalgia; 1987 Jun; 7(2):93-9. PubMed ID: 3111715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased monocyte procoagulant activity in patients with systemic lupus erythematosus.
    Ternisien C; Ollivier V; Chollet-Martin S; de Prost D
    Nouv Rev Fr Hematol (1978); 1990; 32(5):373-5. PubMed ID: 2099414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
    Raleigh-Rosendo R; Diez-Ewald M; Vizcaíno G; Fereira H; Arteaga-Vizcaíno M; Arreaza M
    Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of prostacyclin production from vascular endothelial cells by plasma, serum and platelets under normal and pathological conditions.
    Seid JM; Jones PB; Hughes P; Russell RG
    Agents Actions Suppl; 1982; 11():83-92. PubMed ID: 6758553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.
    Nagasawa K; Ishii Y; Mayumi T; Tada Y; Ueda A; Yamauchi Y; Kusaba T; Niho Y
    Ann Rheum Dis; 1989 Aug; 48(8):672-6. PubMed ID: 2506841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells.
    Hasselaar P; Derksen RH; Oosting JD; Blokzijl L; de Groot PG
    Thromb Haemost; 1989 Sep; 62(2):654-60. PubMed ID: 2510346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant".
    Asherson RA; Lanham JG; Hull RG; Boey ML; Gharavi AE; Hughes GR
    Clin Exp Rheumatol; 1984; 2(1):75-9. PubMed ID: 6442640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Lindsey NJ; Henderson FI; Malia R; Milford-Ward MA; Greaves M; Hughes P
    Br J Rheumatol; 1994 Jan; 33(1):20-6. PubMed ID: 8162452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.